Invention Grant
- Patent Title: Substituted dihydrobenzofuran glycosidase inhibitors
-
Application No.: US16488163Application Date: 2017-08-24
-
Publication No.: US10995090B2Publication Date: 2021-05-04
- Inventor: Anna Quattropani , Santosh S. Kulkarni , Awadut Gajendra Giri
- Applicant: Asceneuron SA
- Applicant Address: CH Lausanne
- Assignee: Asceneuron SA
- Current Assignee: Asceneuron SA
- Current Assignee Address: CH Lausanne
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Thomas J. Paxton
- Priority: IN201621006636 20160225,IN201621006643 20160225
- International Application: PCT/EP2017/071384 WO 20170824
- International Announcement: WO2018/153507 WO 20180830
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/12 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D405/14 ; C07D407/12 ; C07D413/12 ; C07D413/14 ; C07D417/06 ; C07D417/12 ; C07D417/14 ; C07D475/04 ; C07D487/04 ; C07D491/048 ; C07D495/04 ; C07D498/04 ; C07D513/04 ; A61P25/28 ; C07D405/06 ; A61K9/00 ; A61K9/02 ; A61K9/06 ; A61K9/19 ; A61K9/20 ; A61K9/48 ; A61K31/496 ; A61K31/497 ; A61K31/4985 ; C07D405/10
Abstract:
Compounds of formula (I), wherein R′, R″, R, X, W, Q, n, and m have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Public/Granted literature
- US20190388415A1 SUBSTITUTED DIHYDROBENZOFURAN GLYCOSIDASE INHIBITORS Public/Granted day:2019-12-26
Information query
